Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem CellsBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningStem CellsLiver TransplantationTransplantation ChimeraHematologic NeoplasmsWhole-Body IrradiationTissue DonorsPeripheral Blood Stem Cell TransplantationGraft SurvivalBone and BonesLeukemiaHistocompatibility TestingHematopoiesisBusulfanTreatment OutcomeHistocompatibilityKidney TransplantationAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationTransplantation, IsogeneicImmunosuppressive AgentsRetrospective StudiesMice, Inbred C57BLAntigens, CD34Combined Modality TherapyCell DifferentiationTime FactorsLeukemia, Myeloid, AcuteCyclophosphamideHematopoietic Stem Cell MobilizationRemission InductionTransplantation ImmunologyBone Marrow DiseasesBone Marrow PurgingGraft vs Leukemia EffectHepatic Veno-Occlusive DiseaseGraft RejectionHeart TransplantationMyeloablative AgonistsChimerismHematologic DiseasesMyelodysplastic SyndromesColony-Forming Units AssayHLA AntigensCell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMesenchymal Stem Cell TransplantationMultiple MyelomaPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisLung TransplantationFlow CytometrySurvival RateSevere Combined ImmunodeficiencyBone Marrow ExaminationImmunosuppressionCell LineageOrgan TransplantationLymphocyte TransfusionRadiation ChimeraGraft vs Tumor EffectAcute DiseaseLymphocyte DepletionT-LymphocytesDisease-Free SurvivalMelphalanCells, CulturedGranulocyte Colony-Stimulating FactorLeukemia, MyeloidLymphoma, Non-HodgkinBone RemodelingFollow-Up StudiesBone Marrow NeoplasmsCytomegalovirus InfectionsAntineoplastic Combined Chemotherapy ProtocolsTransplantationSiblingsCell SeparationStem Cell NicheVidarabineAntilymphocyte SerumAdult Stem CellsCyclosporineUnrelated DonorsFetal BloodSalvage TherapyCytarabineMesenchymal Stromal CellsPrognosisIslets of Langerhans Transplantation